Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Viral Hepatitis|May 20, 2003
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flaresP Ciccorossi, F Filipponi, F Oliveri, et al.
Journal of Hepatology|November 1, 1996
Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" valuesG Colloredo, G Bellati, G Leandro, et al.
The Journal of Antimicrobial Chemotherapy|June 15, 2007
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatmentF Moriconi, P Colombatto, B Coco, et al.
Italian Journal of Gastroenterology and Hepatology|April 1, 1997
Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferonG Tappero, M Farina, F Negro, et al.
The Italian Journal of Gastroenterology|December 1, 1996
Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver diseaseM R Brunetto, T Suzuki, H Aizaky, et al.
Clinical and Diagnostic Virology|May 1, 1997
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot studyD Flichman, P Colombatto, A Randone, et al.
Italian Journal of Gastroenterology and Hepatology|July 24, 1998
Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trialG Calleri, P Colombatto, M Gozzelino, et al.
The American Journal of Gastroenterology|May 11, 1999
Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferonF Oliveri, T Santantonio, G Bellati, et al.
Journal of Hepatology|December 22, 1999
High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in ItalyP Colombatto, M R Brunetto, J Kansopon, et al.
Journal of Viral Hepatitis|April 23, 2014
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trialP Colombatto, M R Brunetto, A M Maina, et al.
Pageof 4